Related Experiment Videos
Familial Mediterranean fever and seronegative arthritis
1Division of Rheumatology and Immunology, Department of Internal Medicine, Dokuz Eylul University, Faculty of Medicine, Balcova, 35340 Izmir, Turkey. nurullah.akkoc@gmail.com
Abstract:
Familial Mediterranean fever (FMF) is characterized by recurrent, self-limited episodes of polyserositis, with articular involvement also being a common manifestation. The pattern and joint predilection of arthritis show many similarities to those of spondyloarthritis. Moreover, case series suggest an increased prevalence of ankylosing spondylitis or spondyloarthritis among FMF patients. FMF is caused by mutations in the MEFV gene encoding pyrin, which is believed to be involved in regulation of interelukin-1β activation. Recent studies conducted in populations with a high background carrier rate of MEFV variants have reported an increased frequency of M694V among AS patients with no personal or family history of FMF. These findings are of interest, as both candidate gene and genome-wide association studies suggest that the interleukin-1 cytokine pathway may be implicated in the pathogenesis of ankylosing spondylitis. Therefore, association of M694V with ankylosing spondylitis can be recognized as a geographic region-specific risk factor affecting a common inflammatory pathway in the disease pathogenesis.
Insights
Familial Mediterranean fever (FMF) shares arthritis similarities with spondyloarthritis. The MEFV gene variant M694V may be a geographic risk factor for ankylosing spondylitis, impacting a shared inflammatory pathway.
Area of Science:
- Rheumatology
- Genetics
- Immunology
Background:
- Familial Mediterranean fever (FMF) presents with polyserositis and common articular involvement.
- Arthritis in FMF mimics spondyloarthritis, with studies suggesting higher spondyloarthritis prevalence in FMF patients.
- FMF is linked to MEFV gene mutations affecting interleukin-1β regulation.
Purpose of the Study:
- To investigate the association between the MEFV gene variant M694V and ankylosing spondylitis (AS).
- To explore the role of the interleukin-1 cytokine pathway in AS pathogenesis.
- To identify potential geographic region-specific risk factors for AS.
Main Methods:
- Review of case series on FMF and spondyloarthritis prevalence.
- Analysis of genetic studies on MEFV variants in AS patients.
- Examination of evidence linking interleukin-1 pathway to AS.
Main Results:
- Increased frequency of the MEFV M694V variant found in AS patients without a history of FMF.
- The interleukin-1 cytokine pathway is implicated in AS pathogenesis.
- M694V association with AS suggests a geographic risk factor.
Conclusions:
- The MEFV M694V variant may represent a geographic risk factor for ankylosing spondylitis.
- This association highlights a common inflammatory pathway potentially involved in both FMF and AS.
- Further research is warranted to elucidate the precise role of M694V in AS pathogenesis.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Rocky Mountain Spotted Fever
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Encephalitis l: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...